PubMed:32349115 JSON TXT

Annnotations TAB JSON ListView MergeView

Id	Subject	Object	Predicate	Lexical cue
T1	464-548	DRI_Approach	denotes	Irreversible retinal damage can occur if the exposure to the safe doses is >5 years.
T2	549-650	DRI_Challenge	denotes	It is not known whether exposure to high doses over a short period of time can also cause the damage.
T3	651-785	DRI_Approach	denotes	We recommend that before prescribing CQ or HCQ, history of ocular disease should be obtained to avoid the prescription if appropriate.
T4	786-881	DRI_Approach	denotes	If either agent is to be used, routine baseline ocular examination is not absolutely necessary.
T5	882-991	DRI_Challenge	denotes	Patients who do not have ocular disease should also be informed about the potential risk of retinal toxicity.
T6	992-1068	DRI_Approach	denotes	Both agents, however, have not yet been proven to be beneficial to COVID-19.

Id	Subject	Object	Predicate	Lexical cue
T1	0-11	CHEBI:3638	denotes	Chloroquine
T2	0-11	DG_10	denotes	Chloroquine
T3	0-11	CHEBI:3638	denotes	Chloroquine
T4	16-34	CHEBI:5801	denotes	Hydroxychloroquine
T5	16-34	DG_20	denotes	Hydroxychloroquine
T6	16-34	CHEBI:5801	denotes	Hydroxychloroquine
T7	35-42	UBERON:0000966	denotes	Retinal
T8	86-94	SP_7	denotes	COVID-19
T9	118-129	CHEBI:3638	denotes	chloroquine
T10	118-129	DG_10	denotes	chloroquine
T11	118-129	CHEBI:3638	denotes	chloroquine
T12	139-157	CHEBI:5801	denotes	hydroxychloroquine
T13	139-157	DG_20	denotes	hydroxychloroquine
T14	139-157	CHEBI:5801	denotes	hydroxychloroquine
T15	181-189	SP_7	denotes	COVID-19
T16	446-453	UBERON:0000966	denotes	retinal
T17	477-484	UBERON:0000966	denotes	retinal
T18	710-716	UBERON:0000970	denotes	ocular
T19	834-840	UBERON:0000970	denotes	ocular
T20	907-913	UBERON:0000970	denotes	ocular
T21	974-981	UBERON:0000966	denotes	retinal
T22	1059-1067	SP_7	denotes	COVID-19